Carlsbad, California, United States, August 2025 — Angela Rapattoni has been appointed as Chief Financial Officer at DCN Dx, a leading developer of rapid point-of-care diagnostic tests. In this role, she will lead financial strategy, planning, and governance to support DCN Dx’s continued growth and innovation in the diagnostics sector.
Angela joined DCN Dx in 2023 as Vice President of Finance, where she spent two years overseeing financial operations, planning, and performance. Her work strengthened the company’s financial foundation, ensuring alignment between strategy and long-term growth objectives.
Previously, Angela worked with Saxco International LLC for more than four years, where she progressed through leadership roles including Senior Director, FP&A, Commercial Finance and Pricing, Director, Commercial Finance and Pricing, and Senior Manager, Finance. She played a key role in pricing strategy, commercial finance transformation, and enterprise-level decision support.
Earlier in her career, Angela spent nearly three years at BevMo!, where she advanced to Senior Manager, FP&A, Corporate and Stores, after serving as FP&A Manager, Store Operations. She successfully implemented financial processes that optimized performance across both corporate functions and store operations.
She also gained extensive retail finance expertise at Ross Stores, Inc., where she spent nearly four years as Financial Analyst, Senior Financial Analyst, and Manager supporting strategic sourcing and corporate initiatives. Her early career foundation was built at Deloitte as an Audit Senior, where she provided audit and assurance services to a diverse set of clients in the San Francisco Bay Area.
About DCN Dx
DCN Dx is a global leader in the contract development of rapid point-of-care diagnostic tests. Specializing in immunoassays such as lateral flow, flow-through, and microfluidic formats, the company integrates assay development with device engineering to deliver complete solutions. With an ISO 9001:2015 certified process, DCN Dx ensures high sensitivity, quantification, multiplexing, and reader integration to meet the toughest performance standards. Its collaborative approach and expertise support clients worldwide in bringing innovative diagnostics to market.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
